Recent studies reported that DSS colitis severity is associated with increased production of various inflammatory mediators such as TNF-α, IL-1β, and MPO activity; and IL-10 and TGF-β drive anti-inflammatory response to prevent colitis [44, 45]. This evidence concerns the gene IL10 and colitis.